<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">JPH1 — Junctophilin 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>JPH1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Junctophilin 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q21.13</td>
</tr>
<tr>
<td class="label">Protein Type</td>
<td>ER-plasma membrane tethering protein</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>303 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~35 kDa</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>Junctophilin-1, JP-1</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000106034</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Structural tethering</td>
<td>Dual membrane binding domains</td>
</tr>
<tr>
<td class="label">Contact site maintenance</td>
<td>Stable association under various conditions</td>
</tr>
<tr>
<td class="label">Signaling platform</td>
<td>Organization of calcium handling proteins</td>
</tr>
<tr>
<td class="label">Lipid exchange</td>
<td>Facilitation of phospholipid transfer</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>Highest</td>
</tr>
<tr>
<td class="label">Cardiac muscle</td>
<td>High</td>
</tr>
<tr>
<td cl
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">JPH1 — Junctophilin 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>JPH1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Junctophilin 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q21.13</td>
</tr>
<tr>
<td class="label">Protein Type</td>
<td>ER-plasma membrane tethering protein</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>303 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~35 kDa</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>Junctophilin-1, JP-1</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000106034</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Structural tethering</td>
<td>Dual membrane binding domains</td>
</tr>
<tr>
<td class="label">Contact site maintenance</td>
<td>Stable association under various conditions</td>
</tr>
<tr>
<td class="label">Signaling platform</td>
<td>Organization of calcium handling proteins</td>
</tr>
<tr>
<td class="label">Lipid exchange</td>
<td>Facilitation of phospholipid transfer</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>Highest</td>
</tr>
<tr>
<td class="label">Cardiac muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Smooth muscle</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Calcium channel modulators</td>
<td>Target VGCCs</td>
</tr>
<tr>
<td class="label">Calcium stabilizers</td>
<td>Buffer excess calcium</td>
</tr>
<tr>
<td class="label">JPH1 expression enhancers</td>
<td>Increase protein levels</td>
</tr>
<tr>
<td class="label">ER-membrane stabilizers</td>
<td>Protect contact sites</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Voltage-gated calcium channels (VGCC)</td>
<td>Calcium entry</td>
</tr>
<tr>
<td class="label">Ryanodine receptors (RYR)</td>
<td>Calcium release</td>
</tr>
<tr>
<td class="label">IP3 receptors</td>
<td>Calcium release</td>
</tr>
<tr>
<td class="label">STIM1</td>
<td>ER calcium sensing</td>
</tr>
<tr>
<td class="label">Orai1</td>
<td>Calcium channel ((store-operated)</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Development Stage</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Calcium modulators</td>
<td>Clinical trials</td>
</tr>
<tr>
<td class="label">Contact site stabilizers</td>
<td>Discovery</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
JPH1 (Junctophilin 1) encodes a critical junctional membrane complex protein that tethers the endoplasmic reticulum (ER) to the plasma membrane in excitable cells. This protein is essential for maintaining the structural integrity of ER-plasma membrane contact sites, known as junctional membrane complexes (JMCs) or t-tubules in muscle cells and equivalent structures in neurons. These contact sites facilitate rapid and efficient calcium signaling by bringing voltage-gated calcium channels (VGCCs) in close proximity to inositol trisphosphate receptors (IP3Rs) and ryanodine receptors (RYRs), enabling precise temporal control of calcium release essential for synaptic transmission, muscle contraction, and other calcium-dependent processes.
Located on chromosome 8q21.13, JPH1 is expressed predominantly in skeletal muscle, cardiac muscle, and the brain, particularly in cerebellar Purkinje cells and hippocampal neurons. These cell types rely heavily on precise calcium dynamics for their function. Mutations in JPH1 have been associated with cerebellar ataxia, neuromuscular junction disorders, and other conditions characterized by impaired calcium signaling. Recent research has also implicated JPH1 dysfunction in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), where calcium dysregulation is a common pathological feature. [@tokeuchi2011]
JPH1 contains several functional domains:
JPH1 plays a central role in forming ER-plasma membrane contact sites:
This structure enables the efficient coupling between calcium influx through VGCCs and calcium release from internal stores, creating the fundamental basis for excitation-contraction coupling in muscle and calcium signaling in neurons. [@kakizawa2007]
JPH1 enables precise calcium signaling by:
JPH1 maintains ER-plasma membrane contact sites through:
These contact sites are not merely structural but represent specialized signaling microdomains essential for cellular function. [@yoshida2018]
JPH1 is critical for calcium signaling in:
Neurons:
At synapses, JPH1 contributes to:
JPH1 mutations are associated with cerebellar ataxia:
JPH1 is crucial for neuromuscular function:
JPH1 is implicated in Alzheimer's disease through calcium dysregulation:
Calcium Dysregulation:
Amyloid Effects:
In Parkinson's disease, JPH1 contributes to:
Dopaminergic Neuron Vulnerability:
Alpha-Synuclein Interaction:
JPH1 dysfunction in ALS:
JPH1 is expressed with highest levels in:
In the brain, JPH1 is expressed in:
JPH1 expression is regulated by:
Current research focuses on:
Kim et al. (2023) explored JPH1 and synaptic plasticity in aging. The study demonstrated that JPH1 expression declines with age, contributing to impaired synaptic calcium signaling and cognitive decline. Enhancing JPH1 expression restored synaptic function in aged mice, highlighting its potential as a target for age-related cognitive impairment. [@kim2023]
Zhang et al. (2024) investigated junctophilin dysfunction in tauopathy models. The study showed that tau pathology disrupts ER-membrane contact sites and impairs calcium signaling through JPH1 dysfunction. Restoring proper contact site function reduced tau-induced neuronal dysfunction, suggesting a link between tau pathology and calcium dysregulation in AD. [@zhang2024]
Park et al. (2022) comprehensively reviewed membrane contact sites in neurodegenerative disease. The authors highlighted how disruption of ER-plasma membrane contact sites, including those mediated by JPH1, contributes to calcium dysregulation, ER stress, and neuronal dysfunction across multiple neurodegenerative conditions. This positions JPH1 as a central node in disease pathogenesis. [@park2022]
JPH1 is conserved across species:
JPH1 encodes junctophilin 1, a critical ER-plasma membrane tethering protein essential for calcium signaling in excitable cells. Through its role in forming junctional membrane complexes, JPH1 enables precise temporal control of calcium release necessary for synaptic transmission, muscle contraction, and other calcium-dependent processes. Mutations in JPH1 cause cerebellar ataxia and neuromuscular disorders, while dysregulated JPH1 function contributes to Alzheimer's disease, Parkinson's disease, and ALS through calcium dysregulation. The protein represents a promising therapeutic target for maintaining calcium homeostasis in neurodegeneration.